FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

422201009: Tablet for conventional release cutaneous solution (dose form)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2616696018 Tablet for cutaneous solution en Synonym Active Entire term case insensitive SNOMED CT core module
3558858010 Tablet for conventional release cutaneous solution (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3558859019 Tablet for conventional release cutaneous solution en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tablet for conventional release cutaneous solution Is a Tablet false Inferred relationship Existential restriction modifier
Tablet for conventional release cutaneous solution Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Tablet for conventional release cutaneous solution Is a Cutaneous dose form true Inferred relationship Existential restriction modifier
Tablet for conventional release cutaneous solution Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Tablet for conventional release cutaneous solution Has dose form transformation Dissolve true Inferred relationship Existential restriction modifier
Tablet for conventional release cutaneous solution Has dose form intended site Cutaneous true Inferred relationship Existential restriction modifier
Tablet for conventional release cutaneous solution Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Tablet for conventional release cutaneous solution Has basic dose form Tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Potassium permanganate 400mg tablet for conventional release cutaneous solution Has manufactured dose form False Tablet for conventional release cutaneous solution Inferred relationship Existential restriction modifier
Product containing precisely potassium permanganate 400 milligram/1 each tablet for conventional release cutaneous solution (clinical drug) Has manufactured dose form True Tablet for conventional release cutaneous solution Inferred relationship Existential restriction modifier
Permitabs 400mg tablets (Centrapharm Ltd) 30 tablet Has dispensed dose form True Tablet for conventional release cutaneous solution Inferred relationship Existential restriction modifier
Potassium permanganate 400mg tablet for solution Has dispensed dose form False Tablet for conventional release cutaneous solution Inferred relationship Existential restriction modifier
Permitabs 400mg tablets (Centrapharm Ltd) Has dispensed dose form True Tablet for conventional release cutaneous solution Inferred relationship Existential restriction modifier
Potassium permanganate 400mg solution tablets 30 tablet Has dispensed dose form True Tablet for conventional release cutaneous solution Inferred relationship Existential restriction modifier
EN-Potab 400mg tablets for cutaneous solution (Ennogen Healthcare Ltd) Has dispensed dose form True Tablet for conventional release cutaneous solution Inferred relationship Existential restriction modifier
EN-Potab 400mg tablets for cutaneous solution (Ennogen Healthcare Ltd) 30 tablet Has dispensed dose form True Tablet for conventional release cutaneous solution Inferred relationship Existential restriction modifier
Potassium permanganate 400mg tablets for cutaneous solution (Ennogen Pharma Ltd) Has dispensed dose form False Tablet for conventional release cutaneous solution Inferred relationship Existential restriction modifier
Potassium permanganate 400mg tablets for cutaneous solution (Ennogen Pharma Ltd) 30 tablet Has dispensed dose form False Tablet for conventional release cutaneous solution Inferred relationship Existential restriction modifier
Potassium permanganate 400mg tablet for solution Has manufactured dose form False Tablet for conventional release cutaneous solution Inferred relationship Existential restriction modifier
Potassium permanganate 400mg tablets for cutaneous solution Has dispensed dose form True Tablet for conventional release cutaneous solution Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start